Adaptive Biotechnologies Corp. (NASDAQ:ADPT) Forecast To Rise 21.0% To Reach Consensus Target Price
Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.93 and has seen 1.59 million shares traded in the last trading session. The company, currently